- Home
- CNET vs MBIO Comparison
CNET vs MBIO Comparison
Compare CNET & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNET | MBIO |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CNET | MBIO |
|---|---|---|
| Price | $1.29 | $0.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.7K | ★ 72.4K |
| Earning Date | 11-14-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,166,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.96 | $0.89 |
| 52 Week High | $2.78 | $7.00 |
Technical Indicators
Market Signals| Indicator | CNET | MBIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 39.25 |
| Support Level | $1.22 | $1.07 |
| Resistance Level | $1.37 | $1.20 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 31.72 | 29.63 |
Price Performance
Historical ComparisonAbout CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.